Home > News > Top Stories > Signify Health Receives NCQA’s HEDIS Allowable Adjustments Certification

Health Technology

Signify Health Receives NCQA’s HEDIS Allowable Adjustments Certification

Signify Health

Signify Health a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare networks to create and power value-based payment programs, has again achieved the National Committee for Quality Assurance certification for the Healthcare Effectiveness Data and Information Set. This is the second year in which the Company has received this certification.

NCQA provides accreditations and certifications to evaluate a wide range of organizations across the healthcare system. More than 90 percent of health plans in the United States, covering 190 million people, rely on NCQA’s HEDIS measurement tool.

The methodology that Signify Health uses to identify Medicare members who have gaps in their care and would benefit from in-home diagnostic testing was evaluated and certified by NCQA. Receiving this certification allows Signify Health to provide services that align with the industry's most rigorous data assessment processes, resulting in more accurate and timely clinical services for eligible members.

“Through our comprehensive data set and analytics, Signify Health is able to effectively identify at-risk patients and connect them with the appropriate diagnostic and preventive services. We are proud to once again have achieved this NCQA certification, demonstrating our ability to effectively identify gaps in care and to support access to high-quality health services.”

Marc Rothman, MD, Chief Medical Officer, Signify Health

NCQA HEDIS measures relate to many of the most significant chronic health conditions facing seniors in Medicare. In 2021, Signify Health announced the certifications for diabetes care, kidney health evaluation in patients with diabetes, colorectal cancer screening, and osteoporosis management in women.

In 2022, Signify Health was recertified for all of the measures from 2021 that are still recognized by NCQA and expanded its certification to include osteoporosis screening as a preventive measure for older women who have not had a fracture. Osteoporosis is a serious bone disease that impacts the quality of life, especially for women aged 67-85. With the appropriate screenings and interventions, the risk of future bone fractures related to osteoporosis can be reduced.

HEDIS® is a registered trademark of the National Committee for Quality Assurance. NCQA Measure Certification Program™ is a trademark of the National Committee for Quality Assurance.

About Signify Health
Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. Our mission is to build trusted relationships to make people healthier. Our solutions support value-based payment programs by aligning financial incentives around outcomes, providing tools to health plans and healthcare organizations designed to assess and manage risk and identify actionable opportunities for improved patient outcomes, coordination and cost-savings. Through our platform, we coordinate what we believe is a holistic suite of clinical, social, and behavioral services to address an individual’s healthcare needs and prevent adverse events that drive excess cost, all while shifting services towards the home.

About NCQA
NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set is the most widely used performance measurement tool in health care. 

Spotlight

More featured news

Spotlight

Related News

Health Technology

Emory Healthcare Teams Up with DrFirst to Enhance Medication Adherence

Emory Healthcare | November 06, 2023

Emory Healthcare aims to improve prescription affordability and medication outcomes by offering comprehensive, real-time data, including patient out-of-pocket drug costs. Emory is optimizing clinician workflows and enhancing patient medication adherence with Fuzion through DrFirst's three medication management services. UPMC Health System employs AI-driven virtual assistants to address medication nonadherence, engaging high-risk patients via SMS or robocall messages before and between prescription fills. Emory Healthcare and DrFirst have collaborated to address medication adherence by providing comprehensive data at the point of care, including options for patients to assess out-of-pocket drug costs. Emory aims to aid patients in achieving prescription affordability and enhancing their medication outcomes. Emory Healthcare has implemented three medication management services available within the Fuzion platform by DrFirst, which offer clinicians access to medication histories. This initiative aims to streamline clinician workflows and enhance medication adherence among patients. This development holds importance in its potential to decrease adverse drug events for Emory Healthcare patients and provide them with AI-driven information about prescription costs during medical visits, thereby fostering transparency and informed decision-making. DrFirst's advanced medication management platform can enhance electronic prescribing workflows by optimizing the usability of clinical data. This platform is capable of electronically completing prior authorizations and addressing claim rejections. Furthermore, it provides real-time prescription drug benefits and pricing information, enabling physicians to discuss medication costs with their patients and potentially transition to more cost-effective therapeutic alternatives. This can reduce prescription abandonment rates and, consequently, enhance overall health outcomes. G. Cameron Deemer, CEO of DrFirst, said. For many patients, especially those with chronic conditions, taking their medications as prescribed is vital to positive health outcomes and staying out of the hospital. [Source – Healthcare IT News] DrFirst believes that precise and comprehensive medication data contributes significantly to patient safety. Additionally, presenting an entire year's worth of patient medication history can expedite medication reconciliation procedures for healthcare providers. Furthermore, providing drug-allergy, dosing, and duplicate therapy alerts directly to clinicians at the point of care supplies them with valuable information. The integration of technology aids in rendering clinical data more user-friendly and facilitates smoother workflows, ultimately aiding clinicians and patients in achieving improved medication outcomes. Emory Healthcare is set to implement HIPAA-compliant automated patient messaging for electronic prescription alerts. This system will allow patients to review their prescriptions and receive relevant patient education materials, among other features. As for the broader trend, the adoption of AI for improving medication adherence has demonstrated its effectiveness, leading to positive outcomes in both clinical and financial aspects.

Read More

Health Technology, Digital Healthcare

Launch of RICOH Remote Patient Monitoring Enablement Designed to Help Ease Healthcare Staffing Challenges Amid Unprecedented Industry Burnout Crisis

PR Newswire | October 06, 2023

Ricoh USA, Inc. announces the launch of RICOH Remote Patient Monitoring (RPM) Enablement, the newest end-to-end managed services offering for health systems that is designed to help fuel more efficient and sustainable RPM workflows that can lead to improved patient and care delivery team experiences. RICOH RPM Enablement comes at a time when health systems are grappling with a simultaneous monumental shift to virtual care delivery and an unprecedented shortage of healthcare workers. This care worker shortage has reached a nationwide crisis level where there aren't nearly enough healthcare staff to fill vital RPM management roles, leading to alarming care gaps impacting the most vulnerable patient populations. RICOH RPM Enablement is designed to help health systems close this gap and to help lead to improved patient experiences by integrating into existing virtual care programs to support the deployment of remote patient monitoring system devices, inventory tracking, logistics, and device returns. The healthcare worker burnout and staffing shortage – most recently worsened by COVID – is putting extraordinary constraints on health systems to staff RPM management roles, which limits their ability to scale virtual programs and impacts the standard of patient care. According to the Surgeon General, 98% of healthcare workers worry about their own burnout1, which is likely accelerating nurse retirement, fueling a shortfall of 1.1 million registered nurses1. The Mayo Clinic's research has also revealed that U.S. doctor burnout has reached an all-time high of 63%2. Additionally, 98% of clinicians are concerned that burnout can reduce quality of care and 82% of the public believes that a worker shortage will impact their health3. Technology can be the difference maker in systemic change – and clinicians agree as 50-70% welcome the change to use technologies in their work4. "Clinicians currently spend over 50% of their working hours using EHRs5. That's their reality and a massive contributor to burnout, so our mission is centered on pivoting that time back to patient care through supporting the modernization, automation, and enablement of the care workflows that are most critical to health system's success," said Rory Fitzpatrick, Vice President, Industry Vertical Marketing, Ricoh North America. RPM Enablement is the latest demonstration of our commitment. In this period of burnout crisis, the healthcare industry has an opportunity to commit to workers' emotional and physical wellbeing – and Ricoh is dedicated to supporting positive systemic change with sustainable, scalable solutions. [Source: PR Newswire] RPM is often considered one of the largest value drivers of virtual care with applications from primary care through chronic disease management. In fact, when RPM is part of a care plan, the Mayo Clinic has shown that 72.5% of remote patient monitoring patients comply with the care plan's tasks, including taking medications and monitoring vitals6. Further, only 9.4% were readmitted within 30 days versus 20% of patients not using RPM6. Ricoh is uniquely positioned to help address workflow challenges resulting from the qualified healthcare worker shortage due to its large footprint and depth of managed services experience in the industry. Ricoh currently supports thousands of healthcare organizations with various aspects of their business, including 9 out of 11 of the largest for-profit hospital systems and 22 out of 32 of the largest nonprofit hospital systems, with about 3,200 facilities under its support – and is also responsible for managing over 1 million devices in the United States through more than 2,100 U.S. field technicians across various industries.

Read More

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More

Health Technology

Emory Healthcare Teams Up with DrFirst to Enhance Medication Adherence

Emory Healthcare | November 06, 2023

Emory Healthcare aims to improve prescription affordability and medication outcomes by offering comprehensive, real-time data, including patient out-of-pocket drug costs. Emory is optimizing clinician workflows and enhancing patient medication adherence with Fuzion through DrFirst's three medication management services. UPMC Health System employs AI-driven virtual assistants to address medication nonadherence, engaging high-risk patients via SMS or robocall messages before and between prescription fills. Emory Healthcare and DrFirst have collaborated to address medication adherence by providing comprehensive data at the point of care, including options for patients to assess out-of-pocket drug costs. Emory aims to aid patients in achieving prescription affordability and enhancing their medication outcomes. Emory Healthcare has implemented three medication management services available within the Fuzion platform by DrFirst, which offer clinicians access to medication histories. This initiative aims to streamline clinician workflows and enhance medication adherence among patients. This development holds importance in its potential to decrease adverse drug events for Emory Healthcare patients and provide them with AI-driven information about prescription costs during medical visits, thereby fostering transparency and informed decision-making. DrFirst's advanced medication management platform can enhance electronic prescribing workflows by optimizing the usability of clinical data. This platform is capable of electronically completing prior authorizations and addressing claim rejections. Furthermore, it provides real-time prescription drug benefits and pricing information, enabling physicians to discuss medication costs with their patients and potentially transition to more cost-effective therapeutic alternatives. This can reduce prescription abandonment rates and, consequently, enhance overall health outcomes. G. Cameron Deemer, CEO of DrFirst, said. For many patients, especially those with chronic conditions, taking their medications as prescribed is vital to positive health outcomes and staying out of the hospital. [Source – Healthcare IT News] DrFirst believes that precise and comprehensive medication data contributes significantly to patient safety. Additionally, presenting an entire year's worth of patient medication history can expedite medication reconciliation procedures for healthcare providers. Furthermore, providing drug-allergy, dosing, and duplicate therapy alerts directly to clinicians at the point of care supplies them with valuable information. The integration of technology aids in rendering clinical data more user-friendly and facilitates smoother workflows, ultimately aiding clinicians and patients in achieving improved medication outcomes. Emory Healthcare is set to implement HIPAA-compliant automated patient messaging for electronic prescription alerts. This system will allow patients to review their prescriptions and receive relevant patient education materials, among other features. As for the broader trend, the adoption of AI for improving medication adherence has demonstrated its effectiveness, leading to positive outcomes in both clinical and financial aspects.

Read More

Health Technology, Digital Healthcare

Launch of RICOH Remote Patient Monitoring Enablement Designed to Help Ease Healthcare Staffing Challenges Amid Unprecedented Industry Burnout Crisis

PR Newswire | October 06, 2023

Ricoh USA, Inc. announces the launch of RICOH Remote Patient Monitoring (RPM) Enablement, the newest end-to-end managed services offering for health systems that is designed to help fuel more efficient and sustainable RPM workflows that can lead to improved patient and care delivery team experiences. RICOH RPM Enablement comes at a time when health systems are grappling with a simultaneous monumental shift to virtual care delivery and an unprecedented shortage of healthcare workers. This care worker shortage has reached a nationwide crisis level where there aren't nearly enough healthcare staff to fill vital RPM management roles, leading to alarming care gaps impacting the most vulnerable patient populations. RICOH RPM Enablement is designed to help health systems close this gap and to help lead to improved patient experiences by integrating into existing virtual care programs to support the deployment of remote patient monitoring system devices, inventory tracking, logistics, and device returns. The healthcare worker burnout and staffing shortage – most recently worsened by COVID – is putting extraordinary constraints on health systems to staff RPM management roles, which limits their ability to scale virtual programs and impacts the standard of patient care. According to the Surgeon General, 98% of healthcare workers worry about their own burnout1, which is likely accelerating nurse retirement, fueling a shortfall of 1.1 million registered nurses1. The Mayo Clinic's research has also revealed that U.S. doctor burnout has reached an all-time high of 63%2. Additionally, 98% of clinicians are concerned that burnout can reduce quality of care and 82% of the public believes that a worker shortage will impact their health3. Technology can be the difference maker in systemic change – and clinicians agree as 50-70% welcome the change to use technologies in their work4. "Clinicians currently spend over 50% of their working hours using EHRs5. That's their reality and a massive contributor to burnout, so our mission is centered on pivoting that time back to patient care through supporting the modernization, automation, and enablement of the care workflows that are most critical to health system's success," said Rory Fitzpatrick, Vice President, Industry Vertical Marketing, Ricoh North America. RPM Enablement is the latest demonstration of our commitment. In this period of burnout crisis, the healthcare industry has an opportunity to commit to workers' emotional and physical wellbeing – and Ricoh is dedicated to supporting positive systemic change with sustainable, scalable solutions. [Source: PR Newswire] RPM is often considered one of the largest value drivers of virtual care with applications from primary care through chronic disease management. In fact, when RPM is part of a care plan, the Mayo Clinic has shown that 72.5% of remote patient monitoring patients comply with the care plan's tasks, including taking medications and monitoring vitals6. Further, only 9.4% were readmitted within 30 days versus 20% of patients not using RPM6. Ricoh is uniquely positioned to help address workflow challenges resulting from the qualified healthcare worker shortage due to its large footprint and depth of managed services experience in the industry. Ricoh currently supports thousands of healthcare organizations with various aspects of their business, including 9 out of 11 of the largest for-profit hospital systems and 22 out of 32 of the largest nonprofit hospital systems, with about 3,200 facilities under its support – and is also responsible for managing over 1 million devices in the United States through more than 2,100 U.S. field technicians across various industries.

Read More

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More

More featured news